| Literature DB >> 34927110 |
Daisuke Yoneoka1,2,3,4, Akifumi Eguchi2,3,5, Shuhei Nomura2,3,4, Takayuki Kawashima2,3,6, Yuta Tanoue2,3,7, Michio Murakami8,9, Haruka Sakamoto2,3,4, Keiko Maruyama-Sakurai2, Stuart Gilmour1, Shoi Shi10,11, Hiroyuki Kunishima12, Satoshi Kaneko13, Megumi Adachi3, Koki Shimada2, Yoshiko Yamamoto14, Hiroaki Miyata2,4.
Abstract
BACKGROUND: Optimizing media campaigns for those who were unsure or unwilling to take coronavirus disease (COVID-19) vaccines is required urgently to effectively present public health messages aimed at increasing vaccination coverage. We propose a novel framework for selecting tailor-made media channels and their combinations for this task.Entities:
Keywords: COVID-19; Japan; attitudes towards vaccinations; information source; psychological dispositions
Year: 2021 PMID: 34927110 PMCID: PMC8665235 DOI: 10.1016/j.lanwpc.2021.100330
Source DB: PubMed Journal: Lancet Reg Health West Pac ISSN: 2666-6065
Basic characteristics of 30,053 participants. SA: Single answer, MA: Multiple answer, SD: Standard deviation.
| Age group | ||||||
|---|---|---|---|---|---|---|
| 20-34 yr (Group A) | 35-49 yr (Group B) | 50-64 yr | ≥65 yr | |||
| Sample size | 5419 | 7880 | 8132 | 8622 | ||
| Vacctination attitude (SA) | <0.001 | |||||
| Acceptance | 2259 (41.7) | 3721 (47.2) | 4693 (57.7) | 6196 (71.9) | ||
| Unsure | 2113 (39.0) | 3051 (38.7) | 2728 (33.5) | 1982 (23.0) | ||
| Unwilling | 1047 (19.3) | 1108 (14.1) | 711 (8.7) | 444 (5.1) | ||
| Mean age (SD) | 27.72 (4.04) | 42.45 (4.47) | 57.64 (4.40) | 71.69 (4.61) | <0.001 | |
| Gender (SA) | <0.001 | |||||
| Women | 2768 (51.1) | 3774 (47.9) | 4488 (55.2) | 4560 (52.9) | ||
| Men | 2630 (48.5) | 4091 (51.9) | 3637 (44.7) | 4052 (47.0) | ||
| Other | 21 (0.4) | 15 (0.2) | 7 (0.1) | 10 (0.1) | ||
| Highest Educational Level (SA) | <0.001 | |||||
| Middle school | 157 (2.9) | 243 (3.1) | 125 (1.5) | 319 (3.7) | ||
| High school | 1452 (26.8) | 2201 (27.9) | 2830 (34.8) | 3691 (42.8) | ||
| Junior college | 839 (15.5) | 1747 (22.2) | 1887 (23.2) | 1360 (15.8) | ||
| University | 2671 (49.3) | 3164 (40.2) | 3022 (37.2) | 3023 (35.1) | ||
| Graduate school (master's course) | 261 (4.8) | 418 (5.3) | 204 (2.5) | 156 (1.8) | ||
| Graduate school (doctoral course) | 39 (0.7) | 107 (1.4) | 64 (0.8) | 73 (0.8) | ||
| Occupational type (SA) | <0.001 | |||||
| Agriculture, forestry and fisheries | 49 (0.9) | 58 (0.7) | 35 (0.4) | 60 (0.7) | ||
| Construction | 167 (3.1) | 313 (4.0) | 275 (3.4) | 125 (1.4) | ||
| Manufacturing | 678 (12.5) | 1272 (16.1) | 935 (11.5) | 185 (2.1) | ||
| Information and communications | 244 (4.5) | 354 (4.5) | 247 (3.0) | 59 (0.7) | ||
| Transportation and postal services | 174 (3.2) | 327 (4.1) | 258 (3.2) | 62 (0.7) | ||
| Wholesale and retail trade | 389 (7.2) | 712 (9.0) | 627 (7.7) | 263 (3.1) | ||
| Finance and insurance | 139 (2.6) | 263 (3.3) | 240 (3.0) | 42 (0.5) | ||
| Real estate and goods rental and leasing | 63 (1.2) | 118 (1.5) | 125 (1.5) | 132 (1.5) | ||
| Scientific research, professional and technical services | 74 (1.4) | 142 (1.8) | 130 (1.6) | 64 (0.7) | ||
| Accommodations, food and beverage services | 197 (3.6) | 219 (2.8) | 159 (2.0) | 85 (1.0) | ||
| Living-related and personal services and amusement services | 121 (2.2) | 175 (2.2) | 118 (1.5) | 69 (0.8) | ||
| Education and learning support | 168 (3.1) | 304 (3.9) | 413 (5.1) | 150 (1.7) | ||
| Healthcare and welfare | 483 (8.9) | 635 (8.1) | 547 (6.7) | 224 (2.6) | ||
| Combined services | 60 (1.1) | 73 (0.9) | 73 (0.9) | 33 (0.4) | ||
| Services (not elsewhere classified) | 477 (8.8) | 799 (10.1) | 836 (10.3) | 441 (5.1) | ||
| Public service (not elsewhere classified) | 209 (3.9) | 323 (4.1) | 322 (4.0) | 78 (0.9) | ||
| Students | 641 (11.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Homemaker | 467 (8.6) | 1028 (13.0) | 1891 (23.3) | 3328 (38.6) | ||
| Others | 619 (11.4) | 765 (9.7) | 901 (11.1) | 3222 (37.4) | ||
| Annual household income in 2020 (million JPY) (SA) | <0.001 | |||||
| [0–1) | 531 (9.8) | 501 (6.4) | 595 (7.3) | 482 (5.6) | ||
| [1–2) | 384 (7.1) | 578 (7.3) | 703 (8.6) | 1050 (12.2) | ||
| [2–3) | 727 (13.4) | 824 (10.5) | 902 (11.1) | 1712 (19.9) | ||
| [3–4) | 811 (15.0) | 907 (11.5) | 1043 (12.8) | 1881 (21.8) | ||
| [4–5) | 756 (14.0) | 994 (12.6) | 951 (11.7) | 1148 (13.3) | ||
| [5–6) | 565 (10.4) | 950 (12.1) | 757 (9.3) | 751 (8.7) | ||
| [6–7) | 423 (7.8) | 796 (10.1) | 631 (7.8) | 419 (4.9) | ||
| [7–8) | 348 (6.4) | 668 (8.5) | 619 (7.6) | 343 (4.0) | ||
| [8–9) | 210 (3.9) | 477 (6.1) | 429 (5.3) | 201 (2.3) | ||
| [9–10) | 177 (3.3) | 418 (5.3) | 428 (5.3) | 206 (2.4) | ||
| ≥10 | 487 (9.0) | 767 (9.7) | 1074 (13.2) | 429 (5.0) | ||
| Underlying disease (Do you have an underlying disease?) | ||||||
| Yes (diabetes, heart failure, and COPD, etc.) | 302 (5.6) | 583 (7.4) | 1106 (13.6) | 1986 (23.0) | <0.001 | |
| Information sources about COVID-19 (MA) | ||||||
| Medical professionals | 750 (13.8) | 928 (11.8) | 1076 (13.2) | 1475 (17.1) | <0.001 | |
| Newspapers | 690 (12.7) | 1815 (23.0) | 3153 (38.8) | 4966 (57.6) | <0.001 | |
| Books and magazines | 272 (5.0) | 402 (5.1) | 534 (6.6) | 608 (7.1) | <0.001 | |
| Scientific literature | 105 (1.9) | 119 (1.5) | 92 (1.1) | 90 (1.0) | <0.001 | |
| Television | 3650 (67.4) | 6047 (76.7) | 6973 (85.7) | 7843 (91.0) | <0.001 | |
| Radio | 307 (5.7) | 835 (10.6) | 1061 (13.0) | 1503 (17.4) | <0.001 | |
| Internet news sites | 2322 (42.8) | 4459 (56.6) | 4656 (57.3) | 4579 (53.1) | <0.001 | |
| Search engines (Google, Yahoo, etc.) | 1431 (26.4) | 1970 (25.0) | 1525 (18.8) | 1473 (17.1) | <0.001 | |
| LINE | 624 (11.5) | 521 (6.6) | 501 (6.2) | 480 (5.6) | <0.001 | |
| 115 (2.1) | 163 (2.1) | 155 (1.9) | 173 (2.0) | 0.820 | ||
| 1124 (20.7) | 748 (9.5) | 344 (4.2) | 172 (2.0) | <0.001 | ||
| 236 (4.4) | 115 (1.5) | 52 (0.6) | 28 (0.3) | <0.001 | ||
| YouTube | 431 (8.0) | 434 (5.5) | 382 (4.7) | 360 (4.2) | <0.001 | |
| Medical information websites | 141 (2.6) | 202 (2.6) | 219 (2.7) | 194 (2.3) | 0.288 | |
| Blogs or web pages of celebrities and famous people | 106 (2.0) | 186 (2.4) | 144 (1.8) | 135 (1.6) | 0.002 | |
| Local governments such as prefectures and municipalities | 860 (15.9) | 1788 (22.7) | 2468 (30.3) | 3556 (41.2) | <0.001 | |
| Government | 704 (13.0) | 1189 (15.1) | 1510 (18.6) | 2080 (24.1) | <0.001 | |
| The Novel Coronavirus Expert Meeting | 267 (4.9) | 502 (6.4) | 686 (8.4) | 1007 (11.7) | <0.001 | |
| Family or frieds | 841 (15.5) | 1397 (17.7) | 1683 (20.7) | 2512 (29.1) | <0.001 | |
| Scientists and researchers | 102 (1.9) | 153 (1.9) | 206 (2.5) | 363 (4.2) | <0.001 | |
| Pharmaceutical companies | 73 (1.3) | 94 (1.2) | 62 (0.8) | 75 (0.9) | 0.001 | |
| Other companies excluding pharmaceutical companies | 360 (6.6) | 281 (3.6) | 161 (2.0) | 97 (1.1) | <0.001 | |
Estimated Boolean expressions and OR (95% CI) by age groups using multinomial logic regression models.
| Unsure | Unwilling | |||||||
|---|---|---|---|---|---|---|---|---|
| Boolean expressions | OR | Corresponding sample size | Boolean expressions | OR | Corresponding sample size | |||
| ALL ages: M1 (left, AUC=64.4) and M2 (right, AUC=73.6) | ||||||||
| 1.75 | <0.001 | 3263 | 2.00 | <0.001 | 8542 | |||
| (1.62, 1.89) | (1.47, 2.75) | |||||||
| 1.53 | <0.001 | 18961 | 3.13 | <0.001 | 8080 | |||
| (1.44, 1.62) | (2.58, 3.81) | |||||||
| 0.67 | <0.001 | 10013 | 2.25 | <0.001 | 3585 | |||
| (0.63, 0.71) | (1.84, 2.77) | |||||||
| 20-34 yr (Group A): M3 (left, AUC=66.6) and M4 (right, AUC=69.9) | ||||||||
| 0.51 | <0.001 | 4122 | 0.65 | <0.001 | 202 | |||
| (0.44, 0.60) | (0.57, 0.74) | |||||||
| 0.71 | <0.001 | 3147 | 1.40 | <0.001 | 1036 | |||
| (0.64, 0.79) | (1.20, 1.62) | |||||||
| 1.64 | <0.001 | 991 | 1.28 | <0.001 | 1012 | |||
| (1.42, 1.90) | (1.16, 1.42) | |||||||
| 35-49 yr (Group B): M5 (left, AUC=64.4) and M6 (right, AUC=69.6) | ||||||||
| 2.27 | <0.001 | 1068 | 0.46 | <0.001 | 672 | |||
| (1.89, 2.74) | (0.42, 0.50) | |||||||
| 0.37 | <0.001 | 4339 | 0.51 | <0.001 | 3667 | |||
| (0.29, 0.46) | (0.46, 0.56) | |||||||
| 0.75 | <0.001 | 5699 | 4.02 | <0.001 | 1156 | |||
| (0.68, 0.84) | (3.68, 4.39) | |||||||
| 50-64 yr (Group C): M7 (left, AUC=61.6) and M8 (right, AUC=70.1) | ||||||||
| 0.33 | <0.001 | 1480 | 0.46 | <0.001 | 2793 | |||
| (0.19, 0.54) | (0.35, 0.58) | |||||||
| 2.90 | <0.001 | 908 | 1.92 | <0.001 | 4626 | |||
| (2.45, 3.42) | (1.58, 2.33) | |||||||
| 0.44 | <0.001 | 4548 | 3.41 | <0.001 | 5158 | |||
| (0.36, 0.53) | (2.92, 3.97) | |||||||
| ≥65 yr (Group D): M9 (left, AUC=63.6) and M10 (right, AUC=70.2) | ||||||||
| 0.47 | <0.001 | 1113 | 0.54 | <0.001 | 4122 | |||
| (0.40, 0.56) | (0.44, 0.66) | |||||||
| 0.24 | <0.001 | 971 | 6.63 | <0.001 | 384 | |||
| (0.20, 0.29) | (5.11, 8.57) | |||||||
| 0.43 | <0.001 | 4786 | 0.35 | <0.001 | 6383 | |||
| (0.31, 0.58) | (0.25, 0.50) | |||||||
reference group is acceptance.
estimated odds ratios (OR) are adjusted for socio-demographic and health-related confounders including occupation type, income, educational level, gender and underlying diseases Bold: the associated odds ratio ≤ 1 A: A is TRUE (i.e., use media A) !A: A is FALSE (i.e., not use media A) A ∧ B: A and B are both TRUE A ∨ B: A or B is TRUE Med: Medical professionals, TV: TV program, Exp: The Novel Coronavirus Expert Meeting, Gov: Government, Loc: Local government, Book: Books or magazines, News: Newspapers, LINE: LINE app, Fam: Family or close friends, Pha: Pharmaceutical companies, Com: Company excluding pharmaceutical companies